2seventy bio, Inc. (NASDAQ: TSVT) reported Q2 EPS of $0.45, $1.21 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $8.97 million versus the consensus estimate of $11.08 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.